IPO registrations (S-1, F-1) · Registrants
TETRAPHASE PHARMACEUTICALS INC
- SEC CIK
- 1373707 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2013-02-11, last 2013-11-04; 2 initial registrations, 4 amendments
- Outcome
- Final prospectus filed 2013-03-20; declared effective 2013-03-19
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 480 ARSENAL WAY, Watertown, MA 02472
- EDGAR entity type
- operating
- Insiders and CEO pay
- TETRAPHASE PHARMACEUTICALS INC on the corporate pages
Offering terms
- Proposed price range
- $8.00–$10.00 per share (S-1/A filed 2013-03-19)
- Final price
- $7.00 per share, below the range (424B4 filed 2013-03-20, an initial public offering)
- Shares sold
- 10,714,286
- Gross proceeds
- $75,000,002 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol TTPH
- Lead underwriters
- Barclays; BMO Capital Markets
- Syndicate
- Stifel; JMP Securities; Needham & Company
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: Tetraphase Pharmaceuticals Inc. Fuzzy (name and state)
- Business registration: Tetraphase Pharmaceuticals Inc. Fuzzy (name and state)
- Business registration: Tetraphase Pharmaceuticals, Inc. Fuzzy (name and state)
- Business registration: Tetraphase Pharmaceuticals, Inc. Fuzzy (name and state)
- Business registration: Tetraphase Pharmaceuticals, Inc. Fuzzy (name and state)
- Business registration: TETRAPHASE PHARMACEUTICALS, INC. Fuzzy (name and state)
- Business registration: TETRAPHASE PHARMACEUTICALS, INC. Fuzzy (name and state)
- Business registration: TETRAPHASE PHARMACEUTICALS, INC. Fuzzy (name and state)
- Business registration: TETRAPHASE PHARMACEUTICALS, INC. Fuzzy (name and state)
- Federal award recipient: TETRAPHASE PHARMACEUTICALS INC Fuzzy (name and state)
- Form D issuer: TETRAPHASE PHARMACEUTICALS INC EXACT (CIK (EXACT))
- Lobbying client: TETRAPHASE PHARMACEUTICALS Fuzzy (name and state)
- Lobbying client: TETRAPHASE PHARMACEUTICALS Fuzzy (name and state)
- SEC filer: TETRAPHASE PHARMACEUTICALS INC EXACT (CIK (EXACT))
Filings 12
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2013-02-11 | S-1 | S-1 (registration) | TETRAPHASE PHARMACEUTICALS INC | 0001193125-13-048887 ↗ |
| 2013-02-21 | S-1/A | S-1/A (amendment) | TETRAPHASE PHARMACEUTICALS INC | 0001193125-13-068739 ↗ |
| 2013-03-05 | S-1/A | S-1/A (amendment) | TETRAPHASE PHARMACEUTICALS INC | 0001193125-13-091764 ↗ |
| 2013-03-19 | S-1/A | S-1/A (amendment) | TETRAPHASE PHARMACEUTICALS INC | 0001193125-13-114713 ↗ |
| 2013-03-19 | EFFECT | EFFECT (declared effective) | TETRAPHASE PHARMACEUTICALS INC | 9999999995-13-000746 ↗ |
| 2013-03-20 | 424B4 | 424B4 (final prospectus) | TETRAPHASE PHARMACEUTICALS INC | 0001193125-13-117520 ↗ |
| 2013-10-25 | S-1 | S-1 (registration) | TETRAPHASE PHARMACEUTICALS INC | 0001193125-13-410084 ↗ |
| 2013-11-04 | S-1/A | S-1/A (amendment) | TETRAPHASE PHARMACEUTICALS INC | 0001193125-13-424016 ↗ |
| 2013-11-06 | S-1MEF | S-1MEF (added securities) | TETRAPHASE PHARMACEUTICALS INC | 0001193125-13-430932 ↗ |
| 2013-11-06 | EFFECT | EFFECT (declared effective) | TETRAPHASE PHARMACEUTICALS INC | 9999999995-13-003207 ↗ |
| 2013-11-07 | 424B4 | 424B4 (final prospectus) | TETRAPHASE PHARMACEUTICALS INC | 0001193125-13-432969 ↗ |
| 2014-05-21 | EFFECT | EFFECT (declared effective) | TETRAPHASE PHARMACEUTICALS INC | 9999999995-14-001545 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2013-03-19 | S-1/A | registration statement | $8.00–$10.00 | 8,333,333 | - | Nasdaq TTPH | 5 | primary document; range, price sentence, shares headline, proceeds computed, price outside the range dropped, cover names 5 | document ↗ | |
| 2013-03-20 | 424B4 | final prospectus | $7.00 | 10,714,286 | $75,000,002 | Nasdaq TTPH | 5 | primary document; price sentence, shares headline, proceeds table, cover names 5 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| AFEYAN NOUBAR | TenPercentOwner | 2 | 2013 | ||
| BARUCH THOMAS R | TenPercentOwner | 4 | 2013 | ||
| Blume Frederick R. | TenPercentOwner | 2 | 2013 | ||
| BOHLIN GAREN G | Director | 8 | 2013–2019 | ||
| CMEA Ventures VI GmbH & Co. KG | TenPercentOwner | 4 | 2013 | ||
| CMEA VENTURES VI LP | TenPercentOwner | 4 | 2013 | ||
| CMEA Ventures VI Management, L.P. | TenPercentOwner | 4 | 2013 | ||
| Cole Douglas G. | Director | 4 | 2013 | ||
| Collier David J | TenPercentOwner | 4 | 2013 | ||
| Enriquez Juan | TenPercentOwner | 2 | 2013 | ||
| EXCEL MEDICAL FUND LP | TenPercentOwner | 2 | 2013 | ||
| Excel Medical Ventures, LLC | TenPercentOwner | 2 | 2013 | ||
| Flagship Ventures 2007 General Partner LLC | TenPercentOwner | 2 | 2013 | ||
| Flagship Ventures Fund 2004 L P | TenPercentOwner | 2 | 2013 | ||
| Flagship Ventures Fund 2007, L.P. | TenPercentOwner | 2 | 2013 | ||
| Flagship Ventures General Partner LLC | TenPercentOwner | 2 | 2013 | ||
| FMR LLC | Other; TenPercentOwnerOther | 6 | 2013–2015 | ||
| Freund John Gordon | Director; DirectorOther; Director,TenPercentOwner | 20 | 2013–2019 | ||
| GAGE L PATRICK | Director | 18 | 2013–2020 | ||
| Gullans Steven R. Ph.D. | Director; Director,TenPercentOwner | 4 | 2013–2014 | ||
| Handelsman Karl D. | TenPercentOwner | 2 | 2013 | ||
| Horn Patrick Taylor | Officer | Chief Medical Officer | 11 | 2013–2017 | |
| Howard Paul Anthony | TenPercentOwner | 2 | 2013 | ||
| KANEKO YASUNORI | TenPercentOwner | 3 | 2013–2014 | ||
| KANIA EDWIN M JR | TenPercentOwner | 2 | 2013 | ||
| Lubner David Charles | Officer; Officer,TenPercentOwner | SVP and CFO | 13 | 2013–2015 | |
| Macdonald Guy | Director; Director,Officer; Director,Officer,TenPercentOwner | President and Chief Executive | 34 | 2013–2020 | |
| Mediphase (DP&UP) LLC | TenPercentOwner | 2 | 2013 | ||
| Mediphase II (Annex Fund) LLC | TenPercentOwner | 2 | 2013 | ||
| Mediphase II LLC | TenPercentOwner | 2 | 2013 | ||
| Mediphase II (Select Fund) LLC | TenPercentOwner | 2 | 2013 | ||
| Mediphase Venture Partners (DP&UP) Limited Partnership | TenPercentOwner | 2 | 2013 | ||
| Mediphase Venture Partners II (Annex Fund) Limited Partnership | TenPercentOwner | 2 | 2013 | ||
| MEDIPHASE VENTURE PARTNERS II LP | Director,TenPercentOwner; TenPercentOwner | 2 | 2013 | ||
| Mediphase Venture Partners II (Select Fund) Limited Partnership | TenPercentOwner | 2 | 2013 | ||
| Miller Lawrence G. | TenPercentOwner | 2 | 2013 | ||
| Myers Andrew | TenPercentOwner | 1 | 2013 | ||
| Petrillo Enrico | TenPercentOwner | 2 | 2013 | ||
| Ronn Magnus | TenPercentOwner | 1 | 2013 | ||
| Skyline Venture Management IV, LLC | TenPercentOwner | 3 | 2013–2014 | ||
| Skyline Venture Partners Qualified Purchaser Fund IV L P | TenPercentOwner | 3 | 2013–2014 | ||
| Sohail Faysal A. | TenPercentOwner | 4 | 2013 | ||
| Sutcliffe Joyce A. | Officer | Senior Vice President, Biology | 7 | 2013–2014 | |
| Trias Joaquim | TenPercentOwner | 2 | 2013 | ||
| Watson James F | TenPercentOwner | 4 | 2013 | ||
| Webster Leland | TenPercentOwner | 1 | 2013 | ||
| Xiao Xiao-Yi | TenPercentOwner | 2 | 2013 | ||
| THOMPSON JOHN CRAIG | Officer | Chief Operating Officer | 9 | 2014–2015 | |
| Wysenski Nancy | Director | 7 | 2014–2019 | ||
| HOFFMAN STEPHEN J | TenPercentOwner | 1 | 2014 | ||
| Chodakewitz Jeffrey | Director | 7 | 2014–2019 | ||
| Stahl Maria D | Officer | CBO and General Counsel; See Remarks; SVP and General Counsel | 10 | 2015–2020 | |
| HENWOOD GERALDINE | Director | 6 | 2015–2019 | ||
| Giroir L. Patrick Jr. | Director; Other | 2 | 2015 | ||
| Watt Christopher | Officer | Senior Vice President, Finance; SVP, Finance; VP, Finance | 7 | 2016–2020 | |
| Dumas Jacques | Officer | Chief ScientificOfficer | 11 | 2016–2019 | |
| Unninayar Kamalam | Officer | Chief Financial Officer | 3 | 2017–2018 | |
| Tsai Larry | Officer | Chief Medical Officer | 4 | 2018–2019 | |
| Edwards Larry G. | Director,Officer; Officer | Chief Operating Officer; President and CEO; See Remarks | 5 | 2018–2020 | |
| ARMISTICE CAPITAL, LLC | Director,TenPercentOwner | 2 | 2020 | ||
| Armistice Capital Master Fund Ltd. | Director,TenPercentOwner; TenPercentOwner | 2 | 2020 | ||
| Boyd Steven | Director,TenPercentOwner | 2 | 2020 | ||
| Maher Illya Keith | Director | 1 | 2020 | ||
| LA JOLLA PHARMACEUTICAL CO | TenPercentOwner | 3 | 2020 | ||
| La Jolla Pharmaceutical Holdings, LLC | TenPercentOwner | 1 | 2020 | ||
| TTP Merger Sub, Inc. | TenPercentOwner | 1 | 2020 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2020-01-28 | TETRAPHASE PHARMACEUTICALS INC | Pharmaceuticals | $9,997,939 | $9,997,939 | 1 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Business registration | Tetraphase Pharmaceuticals Inc. | MA | State business registries | name and state |
| Business registration | Tetraphase Pharmaceuticals Inc. | MA | State business registries | name and state |
| Business registration | Tetraphase Pharmaceuticals, Inc. | MA | State business registries | name and state |
| Business registration | Tetraphase Pharmaceuticals, Inc. | MA | State business registries | name and state |
| Business registration | Tetraphase Pharmaceuticals, Inc. | MA | State business registries | name and state |
| Business registration | TETRAPHASE PHARMACEUTICALS, INC. | MA | State business registries | name and state |
| Business registration | TETRAPHASE PHARMACEUTICALS, INC. | MA | State business registries | name and state |
| Business registration | TETRAPHASE PHARMACEUTICALS, INC. | MA | State business registries | name and state |
| Business registration | TETRAPHASE PHARMACEUTICALS, INC. | MA | State business registries | name and state |
| Contractor | TETRAPHASE PHARMACEUTICALS INC | MA | Nonprofit contractors (Form 990) | name and state |
| Plan sponsor | TETRAPHASE PHARMACEUTICALS, INC. | MA | Form 5500 (employee benefit plans) | name and state |
| Federal award recipient | TETRAPHASE PHARMACEUTICALS INC | MA | Federal spending (USAspending) | name and state |
| Form D issuer | TETRAPHASE PHARMACEUTICALS INC | MA | Form D private offerings | CIK (EXACT) |
| IPO registrant | Lyra Therapeutics, Inc. | MA | IPO registrations (S-1, F-1) | same street address and ZIP code, 480 ARSENAL WAY 02472 (FUZZY: a shared address, not proof of a shared organization) |
| Lobbying client | TETRAPHASE PHARMACEUTICALS | MA | Federal lobbying (LDA) | name and state |
| Lobbying client | TETRAPHASE PHARMACEUTICALS | MA | Federal lobbying (LDA) | name and state |
| Paying company | Tetraphase Pharmaceuticals, Inc. | MA | Open Payments (drug and device company payments) | name and state |
| Patent assignee | Tetraphase Pharmaceuticals, Inc. | MA | Patents (USPTO) | name and state |
| SEC filer | TETRAPHASE PHARMACEUTICALS INC | SEC filers (EDGAR) | CIK (EXACT) | |
| Trademark owner | Tetraphase Pharmaceuticals, Inc. | MA | Trademarks (USPTO) | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, MA first:
- ERGO SCIENCE CORP MA
- MILLENNIUM PHARMACEUTICALS INC MA
- ESSENTIAL THERAPEUTICS INC MA
- ARQULE INC MA
- ASCENT PEDIATRICS INC MA
- EPIX Pharmaceuticals, Inc. MA
- PRAECIS PHARMACEUTICALS INC MA
- PARATEK PHARMACEUTICALS INC MA
- PREDIX PHARMACEUTICALS HOLDINGS INC MA
- CervoMed Inc. MA
In other datasets, the same topic (Health) in MA:
- Nonprofit: ABBIE M GRIFFIN HOSPITAL FUND (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health